Publications by authors named "Lucia Negri"

Claim this Profile
T
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system.
Daniela Maftei, Patrizia Ratano, Ilaria Fusco, Veronica Marconi, Silvia Squillace, Lucia Negri

Neuropharmacology· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Prokineticin System to Control Chronic Pain and Inflammation.
Lucia Negri, Daniela Maftei

Curr Med Chem· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor.
Roberta Lattanzi, Daniela Maftei, Lucia Negri, Ilaria Fusco, Rossella Miele

Neuropeptides· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and Pharmacological Activities of 14--Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice.
Roberta Lattanzi, Silvia Rief, Helmut Schmidhammer, Lucia Negri, Mariana Spetea

Front Pharmacol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prokineticins: Neuromodulators and Mediators of Inflammation and Myeloid Cell-Dependent Angiogenesis.
Lucia Negri, Napoleone Ferrara

Physiol Rev· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Involvement of Post-Translational Modifications in Alzheimer's Disease.
Serena Marcelli, Massimo Corbo, Filomena Iannuzzi, Lucia Negri, Fabio Blandini

Curr Alzheimer Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prokineticin system modulation as a new target to counteract the amyloid beta toxicity induced by glutamatergic alterations in an in vitro model of Alzheimer's disease.
Silvia Caioli, Cinzia Severini, Teresa Ciotti, Fulvio Florenzano, Domenico Pimpinella, Lucia Negri

Neuropharmacology· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prokineticins are neuroprotective in models of cerebral ischemia and ischemic tolerance in vitro.
Elisa Landucci, Roberta Lattanzi, Elisabetta Gerace, Tania Scartabelli, Gianfranco Balboni, Lucia Negri

Neuropharmacology· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonism of the Prokineticin System Prevents and Reverses Allodynia and Inflammation in a Mouse Model of Diabetes.
Mara Castelli, Giada Amodeo, Lucia Negri, Roberta Lattanzi, Daniela Maftei

PLoS One· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prokineticin 2 upregulation in the peripheral nervous system has a major role in triggering and maintaining neuropathic pain in the chronic constriction injury model.
Roberta Lattanzi, Daniela Maftei, Veronica Marconi, Fulvio Florenzano, Silvia Franchi, Lucia Negri

Biomed Res Int· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bv8/prokineticin 2 is involved in Aβ-induced neurotoxicity.
Cinzia Severini, Roberta Lattanzi, Daniela Maftei, Veronica Marconi, Maria Teresa Ciotti, Lucia Negri

Sci Rep· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Critical role for prokineticin 2 in CNS autoimmunity.
Mhamad Abou-Hamdan, Massimo Costanza, Elena Fontana, Marco Di Dario, Silvia Musio, Lucia Negri

Neurol Neuroimmunol Neuroinflamm· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new convenient synthetic method and preliminary pharmacological characterization of triazinediones as prokineticin receptor antagonists.
Cenzo Congiu, Valentina Onnis, Alessandro Deplano, Severo Salvadori, Veronica Marconi, Lucia Negri

Eur J Med Chem· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-related changes of protein SUMOylation balance in the AβPP Tg2576 mouse model of Alzheimer's disease.
Robert Nisticò, Caterina Ferraina, Veronica Marconi, Fabio Blandini, Lucia Negri

Front Pharmacol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of Bv8-induced biphasic hyperalgesia: increased excitatory transmitter release and expression.
Milena De Felice, Pietro Melchiorri, Michael H Ossipov, Todd W Vanderah, Frank Porreca, Lucia Negri

Neurosci Lett· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bv8/PK2 and prokineticin receptors: a druggable pronociceptive system.
Lucia Negri, Roberta Lattanzi

Curr Opin Pharmacol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bv8-prokineticins and their receptors: modulators of pain.
Lucia Negri, Roberta Lattanzi

Curr Pharm Biotechnol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of Bv8 in Pichia pastoris to identify structural features for receptor binding.
Rossella Miele, Roberta Lattanzi, Maria Carmela Bonaccorsi di Patti, Alessandro Paiardini, Lucia Negri

Protein Expr Purif· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analogues of both Leu- and Met-enkephalin containing a constrained dipeptide isostere prepared from a Baylis-Hillman adduct.
Roberta Galeazzi, Gianluca Martelli, Eleonora Marcucci, Mario Orena, Samuele Rinaldi, Lucia Negri

Amino Acids· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bv8/Prokineticins and their Receptors A New Pronociceptive System.
Lucia Negri, Roberta Lattanzi, Elisa Giannini, Michela Canestrelli, Annalisa Nicotra

Int Rev Neurobiol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain.
Elisa Giannini, Roberta Lattanzi, Annalisa Nicotra, Antonio F Campese, Paola Grazioli, Lucia Negri

Proc Natl Acad Sci U S A· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conformationally constrained opioid ligands: the Dmt-Aba and Dmt-Aia versus Dmt-Tic scaffold.
Steven Ballet, Debby Feytens, Rien De Wachter, Magali De Vlaeminck, Ewa D Marczak, Lucia Negri

Bioorg Med Chem Lett· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazine compounds as antagonists at Bv8-prokineticin receptors.
Gianfranco Balboni, Ilaria Lazzari, Claudio Trapella, Lucia Negri, Roberta Lattanzi

J Med Chem· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prokineticin receptor agonist Bv8 decreases IL-10 and IL-4 production in mice splenocytes by activating prokineticin receptor-1.
Silvia Franchi, Elisa Giannini, Donatella Lattuada, Roberta Lattanzi, Hui Tian, Lucia Negri

BMC Immunol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulators of pain: Bv8 and prokineticins.
Lucia Negri, Roberta Lattanzi, Elisa Giannini, Pietro Melchiorri

Curr Neuropharmacol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis